Detalhe da pesquisa
1.
Chalcones reloaded: an integration of network pharmacology and molecular docking for type 2 diabetes therapy.
J Biomol Struct Dyn
; : 1-13, 2023 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37643025
2.
Insight on sarcopenic obesity and epicatechin as a promising treatment option.
Diabetes Metab Syndr
; 17(10): 102856, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37742361
3.
A narrative review on the impact of sarcopenic obesity and its psychological consequence in quality of life.
Diabetes Metab Syndr
; 17(9): 102846, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37688926
4.
Drug designing and toxicity screening of halogen and nitrogen-augmented catechin in sarcopenic obesity.
Nat Prod Res
; : 1-6, 2023 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37571993
5.
Pharmacokinetic correlation of structurally modified chalcone derivatives as promising leads to treat tuberculosis.
Future Med Chem
; 15(20): 1903-1913, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37877262
6.
An exploration of the experience of dapagliflozin in clinical practice.
Future Sci OA
; 8(8): FSO816, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36457541
7.
Therapeutic use of Guggulsterone in COVID-19 induced obesity (COVIBESITY) and significant role in immunomodulatory effect.
Obes Med
; 24: 100346, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33942025
8.
Junk food-induced obesity- a growing threat to youngsters during the pandemic.
Obes Med
; 26: 100364, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34580647
9.
Artificial sweetener is a growing threat for metabolic syndrome: why is extra attention required?
Future Sci OA
; 9(8): FSO880, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37621846